Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 9 Motor Activity 7 Prostatic Neoplasms 3 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Insulin Resistance 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Diabetes Mellitus, Type 1 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1

Interventions

Rituximab 168 Cyclophosphamide 142 Peripheral Blood Stem Cell Transplantation 84 fludarabine phosphate 68 Filgrastim 64 Etoposide 63 Radiotherapy 55 Vincristine 47 Prednisone 45 Mycophenolic Acid 44 Melphalan 40 Whole-Body Irradiation 39 Cyclosporine 39 Busulfan 39 Tacrolimus 36 Doxorubicin 34 Cytarabine 33 Lenalidomide 29 Carmustine 28 Antilymphocyte Serum 28 Methotrexate 27 Methylprednisolone 26 Bortezomib 26 Bendamustine Hydrochloride 26 sargramostim 21 ibritumomab tiuxetan 20 obinutuzumab 19 ibrutinib 18 fludarabine 18 Dexamethasone 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, Follicular × High-Intensity Interval Training × Clear all

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡